ClinicalTrials.Veeva

Menu

HIV Disclosure and Medication Adherence, a Pilot Study (RSAD-VIH-11)

U

University Center for Primary Care and Public Health (Unisanté)

Status

Completed

Conditions

HIV Infection

Study type

Observational

Funder types

Other
NETWORK

Identifiers

NCT01621412
RSAD-VIH-2011

Details and patient eligibility

About

The investigators believe that disclosure of HIV status could influence medication adherence. If disclosure leads to social support, adherence could be improved. This study purpose is to assess correlation between disclosure and medication adherence, and to describe people whose HIV status has been disclosed to.

Full description

Pharmacists administer a questionnaire to each consecutive subject taking part in the adherence-enhancing program at the pharmacy of the Department of Ambulatory Care And Community Medicine in Lausanne. This questionnaire assesses disclosure, response to disclosure, and living situation.

Adherence is measured by electronic monitoring and pill count.

Enrollment

120 estimated patients

Sex

All

Ages

18+ years old

Volunteers

No Healthy Volunteers

Inclusion criteria

  • HIV Infection
  • Enrolled in the adherence-enhancing program

Exclusion criteria

  • Inclusion visit
  • Not french or english speaker

Trial contacts and locations

1

Loading...

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2026 Veeva Systems